Acute neuromyopathy after coichicine treatment
Sir: Colchicine is an effective drug to treat and prevent gout and is the best treatment for patients with contraindications to non-steroidal anti-inflammatory drugs. Acute side effects are nausea and diarrhoea, which disappear upon dose reduction or discontinuation of the drug. Severe toxic effects, affecting mainly the nervous system, the liver, and bone marrow, may be caused either by one single toxic dose or by customary doses taken for years in patients with mild renal insufficiency. ' The development of colchicine induced neuromyopathy in a patient after one or two weeks of regular use of colchicine was unexpected. We are not aware of a similar reported case history.
A 66 year old man had progressive muscular weakness. Within two to three weeks he could not walk without support and noticed a numbness in fingers and toes. Nausea and vomiting appeared a few days before admission. Four years earlier a renal transplantation had been performed because of end stage renal failure due to chronic glomerulonephritis. Treatment consisted of prednisolone 10 mg on alternate days and cyclosporin A 3 mg/kg. Renal function was stable with a creatinine clearance of 40-50 ml/min. Four weeks before admission he experienced urate-crystal arthritis and received colchicine initially 0-5 mg orally thrice daily, after 12 days 0-5 mg twice daily.
On admission, the patient was bedridden and unable to turn over. Severe weakness of all muscles of the arms and legs was present. There were no signs of inflammation of the joints. Deep-tendon reflexes were absent. Vibration sense was decreased below the iliac crest. Senses of pinprick, light touch, and position were intact. Blood urea nitrogen was 27-3 mmol/l (concentration before admission 15-5 mmol/l, normal 3 3-6-7) and creatinine 175 imol/l (before admission 140 imol/l, normal 62-106). The sodium and potassium were normal. Uric acid concentration was 0-64 mmol/l (normal <0 45), creatine kinase 634 U/I (normal <50), aspartate aminotransferase 312 U/I (normal <30), alanineaminotransferase 276 U/l (normal <30), and lactate dehydrogenase 835 U/I (normal <235). The thyroid stimulating hormone was normal. The cyclosporin concentration was within the therapeutic range (125 mmol/l). The colchicine concentration was 13 ,ug/l (toxic >5 Rg/l). Myo Both the myopathy and neuropathy showed improvement, but recovery was still not complete at that time.
The findings strongly point to colchicine as the cause of this patient's neuromyopathy. The toxic drug level at admission and rapid improvement after its discontinuation form additional evidence. The toxic effects of colchicine have been extensively studied in animal models, in which it causes an ascending paralysis, mainly of the hind limbs. Markand was the first to describe the ultrastructural changes of colchicine in the skeletal muscle of rats.4 Similar abnormalities were described in a patient with colchicine abuse for several years.5 Subsequently, Kuncl showed that myopathy often occurs in patients with mild renal impairment after the use of regular doses of colchicine for several years.$8
The mechanism of acute colchicine neuromyopathy is unknown. The myopathy is suspected to be an altered autophagic process, and the accompanying neuropathy is likely to be caused by defective axonal transport resulting from impaired microtubule assembly. Our patient had histopathological changes similar to The throat swab (taken by the general practitioner before starting treatment with antibiotics) showed a heavy growth of Lancefield group G streptococci. A left wrist aspirate showed no organisms on Gram staining, and no subsequent growth even after enrichment culture. Five sets of blood cultures were sterile. Antistreptolysin 0 titre was >1000 international units (IU) per millilitre (normal <200). White cell count was 17 5xl09/l (neutrophils 14-9), haemoglobin 143 g/l, platelets 327 x l09/l, erythrocyte sedimentation rate 75 mm/h, C reactive protein 375 mg/l (normal <100), normal biochemistry except for alkaline phosphatase 412 IU/I (normal 80-280), yglutamyltransferase 82 IU/I (normal 10-48), ferritin 839 tg/l (normal 10-385). Rheumatoid factor, antinuclear antibodies, and antineutrophil cytoplasmic antibodies were negative. The following were normal or negative: left wrist and chest radiographs; urine analysis and mid-stream urine culture; electrocardiogram; echocardiogram; viral antibody screen; hepatitis B serology; yersinia, brucella, and borrelia antibodies. HLA class I typing was Al B8 B15.
He was admitted to hospital. Treatment was continued with ampicillin and indomethacin 50 mg three times daily. Over the next 10 days he experienced prolonged morning stiffness and a swinging fever. The neck pain and capsulitis of the right shoulder rapidly settled. There was sequential painful involvement of the left wrist, both supraspinatus tendons, left then right hip, right wrist, and bilateral adductor enthesitis, with each episode lasting 24-72 hours. The erythrocyte sedimentation rate peaked at 128 mm/h four days after admission, and the platelets at 859x 109/l nine days later, returning gradually to normal thereafter. The C reactive protein slowly fell to normal. Indomethacin was discontinued when a mild hepatitic picture developed on the liver function tests, and prednisolone 40 mg daily was introduced. Thereafter, no new joint or enthesopathic symptoms developed, and results of liver function tests were normal. He was discharged 16 days after admission. Within two months all inflammation had subsided with a full return to normal function of all joints. The prednisolone has been tapered rapidly, and the patient has returned to full time employment.
Group G streptococci have been associated with previous reports of septic arthritis,' but the low virulence confines most serious disease to patients with a predisposition to infection.2 There are case reports of sterile reactive arthritis in septicaemic patients.' 3 In this patient there was no evidence of septicaemia, joint aspiration of the wrist showed no growth, and he had been previously well. His subsequent arthritis and enthesitis was flitting and short lasting, which is much more characteristic of reactive and rheumatic fever arthritis4 than of multifocal sepsis, though the distribution of joint and enthesis involvement was unusual. Furthermore, bacteraemia rarely complicates pharyngitis.5 Host antibody responses are poor in streptococcus group G pharyngitis, so that until now no cases of poststreptococcal sequelae have been described in group G pharyngitis. ' 
